Summary
5-Methoxytryptamine (5-MT) is taken up rapidly by rat tissues after IP injection (50 mg/kg) and the following peak levels (μg/g or ml of sample) were observed after 5 min: plasma, 5.3; liver, 126; skeletal muscle, 2.4; brain 0.43. Over 90% of the compound disappeared from the plasma and the tissues studied within 60 min. The compound impaired rope climbing performance of trained rats. Pretreatment of the animals with iproniazid enhanced the effect of 5-MT whereas its main (and probably only) metabolite, 5-methoxyindoleacetic acid, did not interfere with rope climbing at a dose of 75 mg/kg. 5-MT also produced marked cutaneous vasodilatation, analgesia and hindleg paralysis. All pharmacological effects lasted approximately 75 min. It is suggested that 5-MT is the pharmacological active agent and that behavioral changes observed after IP injection of the compound are mainly caused by the peripheral and little, if any, by a central action of this compound.
Similar content being viewed by others
References
Axelrod, J., and H. Weissbach: Purification and properties of hydroxyindole-omethyltransferase. J. biol. Chem. 236, 211–213 (1961).
Bertaccini, G., and T. Vitali: Synthesis and pharmacological activity of some 5-methoxyindole derivatives occurring in nature. II Farmacol. 22, 230–244 (1967).
Brodie, B. B., and S. Udenfriend: The estimation of basic organic compounds and a technique for the appraisal of specificity. J. biol. Chem. 158, 705–714 (1945).
Bulat, M., and Z. Supek: Passage of 5-hydroxytryptamine through the blood brain barrier, its metabolism in the brain and elimination of 5-hydroxyindoleacetic acid from the brain tissue. J. Neurochem. 15, 383–389 (1968).
Curtis, D. R., and R. Davis: Pharmacological studies upon neurones of the lateral geniculate nucleus of the cat. Brit. J. Pharmacol. 18, 217–246 (1962).
Dukor, P., u. R. Schüppli: Konstitutions chemische Verbindungen für die Wirksamkeit von Oxytryptaminederivaten im Strahlenschutzversuch. Experientia (Basel) 17, 257–258 (1961).
Erspamer, V.: Enteramina e 5-metossitriptamina. Tossicita. Azione sulla diuresi, sulla pressione del sangue e su alcuni organi a muscolature liscia. Ric. Sci. 22, 694–702 (1952).
—: Peripheral physiological and pharmacological actions of indolealkylamines. In: Handbook of exp. pharmacol., vol. 19, pp. 245–359. Berlin-Heidelberg-New York: Springer 1966a.
—: Bioassay of indolealkylamines. In: Handbook of exp. pharmacol., vol. 19, pp. 113–131. Berlin-Heidelberg-New York: Springer 1966b.
—, and A. Ottolenghi: Antidiuretic action of enteramine Experientia (Basel) 6, 428 (1951).
— —: Pharmacological studies on enteramine. Arch. int. Pharmacodyn. 93, 177 to 201 (1953).
Franzen, Fr., and H. Gross: Tryptamine, N,N-dimethyltryptamine, N,N-dimethyl-5-hydroxytryptamine and 5-methoxy-tryptamine in human blood and urine. Nature (Lond.) 206, 1052 (1965)
Gessner, P. K., W. M. McIsaac, and I. H. Page: Pharmacological actions of some methoxyindolealkylamines. Nature (Lond.) 190, 179–180 (1961).
Kveder, S., and W. M. McIsaac: The metabolism of melatonin (N-acetyl-5-methoxytryptamine) and 5-methoxytryptamine. J. biol. Chem. 236, 3214–3220 (1961).
Maickel, R. P., and F. P. Miller: Fluorescent products formed by reaction of indole derivatives and O-phthaldialdehyde. Analyt. Chem. 38, 1937–1938 (1966)
—: The fluorometric determination of indolealkylamines in brain and pineal gland. Advanc. pharmacol. 6, 71–77 (1967).
Marley, E.: Behavioral and electrophysiologioal effects of catecholamines. Pharmacol. Rev. 18, 753–768 (1966).
Michaux, R.: Catatonic action of 5-methoxytryptamine. Life Sci. 1, 617–619 (1962).
Sanders, E., and M. T. Bush: Distribution, metabolism and excretion of bufotenine in the rat with preliminary studies of its O-methyl derivative. J. Pharmacol. exp. Ther. 158, 340–352 (1967).
Taylor, F. M., and C. Wilpizeski: Simultaneous recordings of monkey electrocorticograms and electrocardiograms. Delaware med. J. 39, 105–108 (1968).
Vogel, W. H.: Physiological disposition and metabolism of 3,4-dimethoxyphenylethylamine in the rat. Int. J. Neuropharmacol. 7, 373–381 (1968).
Winter, C. A., and L. Flataker: Effect of antihistaminic drugs upon performance of trained rats. J. Pharmacol. exp. Ther. 101, 156–162 (1951).
Author information
Authors and Affiliations
Additional information
This work was supported by grants GRS-1968-08 from the NIH “small” grants program at Jefferson Medical College and MH-15317 from the U.S. Public Health Service, National Institute of Mental Health.
Rights and permissions
About this article
Cite this article
Vogel, W.H. Physiological disposition of 5-methoxytryptamine and the rope climbing performance of rats. Psychopharmacologia 15, 88–95 (1969). https://doi.org/10.1007/BF00407040
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00407040